Chi­nese biotech teams with Lil­ly on car­diometa­bol­ic dis­eases; Sen­ate fi­nance chair goes af­ter BMS

Chi­nese biotech Ab­bisko Ther­a­peu­tics is team­ing up with Eli Lil­ly on a new col­lab­o­ra­tion.

The pair an­nounced Mon­day they will part­ner on car­diometa­bol­ic dis­eases and go af­ter an un­named tar­get, with Ab­bisko el­i­gi­ble for up to $258 mil­lion in mile­stones. Ab­bisko will han­dle pri­mar­i­ly the dis­cov­ery work with in­put from Lil­ly, af­ter which Lil­ly will have the op­tion to fur­ther de­vel­op and po­ten­tial­ly bring the pro­gram to mar­ket.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.